Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection
- 1 December 2006
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 118 (6) , 2409-2417
- https://doi.org/10.1542/peds.2006-1475
Abstract
BACKGROUND. Influenza causes significant morbidity among children. Previous studies used indirect case ascertainment methods with little cost data. We sought to measure the burden of laboratory-confirmed influenza from hospitalized children. METHODS. We conducted a retrospective cohort study during 3 viral seasons at Primary Children's Medical Center (Salt Lake City, UT). Children ≤18 years of age who were hospitalized with laboratory-confirmed influenza infection were included. Outcomes included hospitalization rates, complications including intensive care unit stays, mechanical ventilation, length of stay, and total hospital costs. RESULTS. A total of 325 children had hospitalizations attributable to influenza over 3 viral seasons: 28% 2 years of age; 37% had high-risk medical conditions. Population-based rates of hospitalization for Salt Lake County residents ranged from 6.3 to 252.7 per 100000 children. The highest rates were in children younger than 6 months, and rates decreased with increasing age. Forty-nine (15%) children had an ICU stay; 27 required mechanical ventilation, and half of these patients were >2 years of age. Total hospital cost for the cohort was $2 million; 55% was accounted for by children >2 years of age. Length of stay and total hospital costs were significantly higher in all children >2 years of age compared with children 2 years of age.Keywords
This publication has 32 references indexed in Scilit:
- Estimating Influenza Hospitalizations among ChildrenEmerging Infectious Diseases, 2012
- Severe Pediatric Influenza in California, 2003–2005: Implications for Immunization RecommendationsPublished by American Academy of Pediatrics (AAP) ,2006
- A National Survey of Severe Influenza-Associated Complications among Children and Adults, 2003-2004Clinical Infectious Diseases, 2005
- An economic analysis of annual influenza vaccination of childrenVaccine, 2005
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Influenza A and B Virus Infections in ChildrenClinical Infectious Diseases, 2003
- Clinical and Economic Outcomes of Conventional Amphotericin B–Associated NephrotoxicityClinical Infectious Diseases, 2002
- Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective StudyThe Journal of Infectious Diseases, 2002
- Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortalityJAMA, 1997
- Epidemiology and Cost of Infection with Human Parainfluenza Virus Types 1 and 2 in Young ChildrenClinical Infectious Diseases, 1994